1. Technology Overview
The invention focuses on biological hydrogen sulfide (H₂S) and carbonyl sulfide (COS) donation using thiocarbamates. These compounds release COS, which is then converted to H₂S by hydrolysis or metabolism by carbonic anhydrase. The technology is currently in the development stage, with promising cross-industry applications in biological detection, imaging, and targeted drug delivery.
2. Key Features and Benefits
Slow-Releasing H₂S Donors: Provides sustained release of H₂S in response to external stimuli.
Modular Donation Platform: Allows for modification of triggering moieties and release rates.
Versatility: Applicable to various industries, including biotechnology and pharmaceuticals.
Scalability: Synthesis processes can be scaled for larger quantities.
Targeted Applications: Ideal for biological detection, imaging, and drug delivery systems.
3. Applications and Market Focus
Biological Detection: Use in detecting and imaging biological processes involving H₂S.
Drug Delivery: Integration into targeted drug delivery systems.
Biotechnology: Development of novel biological detection and imaging methods.
Pharmaceutical Industry: Synthesis of complex organic molecules for various applications.
Chemical Industry: Use in advanced synthesis techniques and equipment.
4. Commercial Advantages
Strategic Benefits: Provides reliable and scalable H₂S-releasing compounds for various applications.
Implementation Advantages: Facilitates integration into existing biological detection and imaging systems.
Market Positioning: Positions technology as a key enabler for advanced biological detection and drug delivery systems.
Competitive Advantages: Offers slow-releasing H₂S donors and modular donation platform compared to existing methods.
5. Partnership Opportunities
Ideal Licensing Partners: Biotechnology firms, pharmaceutical companies, chemical industry leaders.
Cross-Sector Partnership Benefits: Collaboration opportunities across biotechnology and pharmaceutical industries.
Diverse Market Opportunities: Potential for global market expansion in regions with strong biotechnology and pharmaceutical industries.
Collaborative Development: Opportunities for joint development of hybrid devices and custom synthesis services.